On a more serious note, a biotech that is capable of taking on debt and staying afloat is a milestone. It speaks volumes that a lender has seen the books and is willing to double the credit line...they are not in the business to foreclose on companies. Would you rather have an equity raise at a discount to market in hopes of 'someday' being able to secure a loan?
News 
Market Data 
Discover 
